Hepatic Resection Versus Transaterial Chemoembolization for BCLC Stage B Child-Pugh A HCC Patients
吴飞翔,张涌泉,向邦德,马良,杨宏志,丛凤云,叶甲舟,刘星,赵荫农
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2013.01.008
2013-01-01
Abstract:Objective To compare the survival outcomes for Barcelona Clinical Liver Cancer staging system (BCLC) stage B,Child-Pugh A,hepatocellular carcinoma (HCC) patients treated with hepatic resection or transarterial chemoembolization (TACE).Methods Between 2003 and 2008,443 patients from the Affiliated Tumor Hospital and Affiliated Minzu Hospital of Guangxi Medical University were retrospectively studied.273 patients underwent hepatic resection and 169 TACE.Repeated TACE was performed.The overall survival and recurrence-free survival between the hepatic resection group and the TACE group were compared using the Kaplan-Meier method.The risk factors of mortality and tumor recurrence were analyzed by the Cox's regression model.Results The 1-,3-,and 5-overall survival rates and recurrence-free survival rates were 70％,46％,37％ and 73％,52％,37％in the hepatic resection group compared with 38％,15％,12％ and 44％,25％,16％ in the TACE group,respectively.The mean overall survival period and recurrence-free survival period were 31.9months and 32.6 months in the hepatic resection group.The corresponding figures for the TACE group were 14.3 months and 13.4 months,respectively.Both the overall survival (P＜0.0001) and the recurrence-free survival (P＜0.0001) were significantly longer in the hepatic resection group than the TACE group.In subgroup analysis for patients with multi-nodules,the 1-,3-,and 5-overall survival rates were 68％,38％ and 30％ in the hepatic resection group compared with 36％,10％,0％ in the TACE group.The corresponding mean overall survival periods for the 2 subgroups were 28.1months and 11.5 months,respectively.For patients with solitary tumor,the 1-,3-,and 5-overall survival rates were 71％,50％,38％ in the hepatic resection group compared with 341％,22％,15％in the TACE group.The corresponding mean overall survival periods for the 2 subgroups were 32.6months and 14.8 month,respectively.The overall survivals (P＜0.0001) in the patients with solitary tumor and those with multi-nodules after hepatic resection were significantly longer than after TACE.Cox regression analyses revealed a solitary tumor＞ 10 cm,multi-nodules,serum albumin≥35 g/L,prothrombin time＞13 sec,alpha fetoprotein＞400 ng/ml,hepatitis B virus positivity and cirrhosis were independent risk factors of survival.A solitary tumor＞l0 cm,multi-nodules,hepatitis B virus positivity and TACE (P＜0.001) were associated with a higher tumor recurrence rate.Conclusions Hepatic resection provided longer survival to BCLC stage B,Child-Pugh A,HCC patients than TACE.